Skip to main content
. 2013 Sep 25;73(14):1569–1586. doi: 10.1007/s40265-013-0117-0

Fig. 6.

Fig. 6

Effects of ivabradine on cardiovascular outcomes in patients with chronic heart failure (HF) and a baseline heart rate ≥75 beats per minute: subanalysis of the SHIFT study. The primary composite endpoint of this study was cardiovascular death or hospital admission for worsening HF. CI confidence interval, HR hazard ratio. Adapted from Böhm et al. [66]